Active Portfolio Ideas: Mergers, Strategic Reviews, Asset Sales, and Litigation Opportunities
SPAR Group's merger with Highwire Capital faces delays, with a 26% spread to offer price and potential 30% nosedive. Kronos Bio's strategic review...
26 Views
SSI Weekly Highlights: Merger Arbs, Acquisition Challenges, and Strategic Buybacks in Focus
Highwire Capital's acquisition of SPAR Group at $2.50/share faces challenges due to financing issues and founder stock sales.
27 Views
Highwire Capital's Acquisition of SPAR Group Faces Uncertainty Amid Financing Issues and Founder Stock Sales
Highwire Capital's $2.50/share offer for SGRP is 60% higher than previous bids, raising concerns about financing.
565 Views
SSI Weekly: WEX Tender Offer, SGRP Gains, OCI Asset Sale, CURN Strategy, and Quick Pitch Updates
WEX Inc. launched a $750m tender offer with an odd-lot provision, targeting to repurchase ~12% of shares. OCI N.V.'s Natgasoline JV dispute...
441 Views
Strategic Reviews, Mergers, and Asset Sales: Analyzing Upside Potential in Active Portfolio Ideas
Sage Therapeutics rejected Biogen's $7.22/share offer, initiating a strategic review for potential sale, indicating a possible higher premium.
249 Views